Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
Kinco Automation (Shanghai) Co.,Ltd
688160
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
FDMT 4D Molecular Therapeutics
- 4.610
- -0.060-1.28%
Close Jan 22 16:00 ET
- 4.800
- +0.190+4.12%
Post 20:01 ET
213.11MMarket Cap-1.62P/E (TTM)
4.800High4.490Low414.33KVolume4.660Open4.670Pre Close1.91MTurnover1.32%Turnover RatioLossP/E (Static)46.23MShares36.25052wk High0.39P/B144.53MFloat Cap4.48052wk Low--Dividend TTM31.35MShs Float55.110Historical High--Div YieldTTM6.64%Amplitude4.480Historical Low4.616Avg Price1Lot Size
About 4D Molecular Therapeutics Company
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.
Company Profile
SymbolFDMT
Company Name4D Molecular Therapeutics
Issue Price23.00
Founded2013
CEOMr. David Kirn, M.D.
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 455
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-505-2680
Company Executives
- Name
- Position
- Salary
- David Kirn, M.D.
- Director and Chief Executive Officer
- 10.29M
- Robert Young Kim, M.D.
- Chief Medical Officer
- 3.96M
- Dr. Fariborz Kamal, PhD
- President and Chief Operating Officer
- 4.54M
- Uneek Mehra
- Chief Business Officer, Chief Financial Officer and Principal Accounting Officer
- --
- Noriyuki Kasahara, M.D.,PhD
- Chief Scientific Officer
- 488.91K
- Dr. John F. Milligan, PhD
- Executive Chairman of the Board
- 581.44K
- Nancy Miller-Rich
- Independent Director
- 340.12K
- Jacob M. Chacko, M.B.A.,M.D.
- Independent Director
- 352.62K
- Dr. Charles P. Theuer, M.D.,PhD
- Independent Director
- 352.62K
- Susannah Gray, M.B.A.
- Independent Director
- 352.62K
- Shawn Cline Tomasello, M.B.A.
- Independent Director
- 345.12K
- Scott Bizily, J.D.,PhD
- Chief Legal and Corporate Secretary
- --
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart